Hikma Offloads Troubled Ex-Boehringer Manufacturing Plants To Xellia
This article was originally published in Scrip
Hikma Pharmaceuticals PLC is selling the manufacturing facilities previously owned by Ben Venue Laboratories, Inc based in Bedford, Ohio, to Xellia Pharmaceuticals. Hikma acquired the Ben Venue manufacturing assets from Boehringer Ingelheim in September 2014. This followed an agreement in May 2014 to acquire Ben Venue's generic injectables business, called Bedford Laboratories.
Register for our free email digests: